PAPER Kaur H, Swadia D, Sinha S
SEARCH RESULTS
340320 RESULTS
PAPER Silva AM, Hickford ES, Cutler P
An immunoassay for the quantification of phosphorylated α-synuclein at serine 129 in human cerebrospinal fluid.
Bioanalysis. 2024 Oct 15;:1-15. PubMed.PAPER Han R, Wang Q, Xiong X, Chen X, Tu Z, Li B, Zhang F, Chen C, Pan M, Xu T, Chen L, Wang Z, Liu Y, He D, Guo X, He F, Wu P, Yin P, Liu Y, Yan X, Li S, Li XJ, Yang W
Deficiency of parkin causes neurodegeneration and accumulation of pathological α-synuclein in monkey models.
J Clin Invest. 2024 Oct 15;134(20) PubMed.PAPER Salimi M, Nazari M, Shahsavar P, Dehghan S, Javan M, Mirnajafi-Zadeh J, Raoufy MR
Olfactory bulb stimulation mitigates Alzheimer's-like disease progression.
CNS Neurosci Ther. 2024 Oct;30(10):e70056. PubMed.PAPER Fonseca E, Lallana S, Ortega G, Cano A, Sarria-Estrada S, Pareto D, Quintana M, Lorenzo-Bosquet C, López-Maza S, Gifreu A, Campos-Fernández D, Abraira L, Santamarina E, Orellana A, Montrreal L, Puerta R, Aguilera N, Ramis M, de Rojas I, Ruiz A, Tárraga L, Rovira À, Marquié M, Boada M, Toledo M
Amyloid deposition in adults with drug-resistant temporal lobe epilepsy.
Epilepsia. 2024 Oct 15; PubMed.PAPER Kanwal M, Sarwar S, Nadeem H, Alghamdi SA, Alamro AA, Malik S, Maqsood S, Alghamdi AA, Tariq MJ, Malik I, Khan AU, Muskan A
Pyrazolone-nicotinic acid derivative (4Z)-4-(2-hydroxybenzylidine)-5-methyl-2-(pyridine-3-ylcarbonyl)-2, 4-dihydro-3H-pyrazole-3-one (IIc) as multitarget inhibitor of neurodegeneration and behavioural impairment in Dementia.
J Pharm Pharmacol. 2024 Oct 14; PubMed.PAPER Dennis AP, Strafella AP
The identification of cognitive impairment in Parkinson's disease using biofluids, neuroimaging, and artificial intelligence.
Front Neurosci. 2024;18:1446878. Epub 2024 Sep 26 PubMed.PAPER Liang C, Pereira R, Zhang Y, Rojas OL
Gut Microbiome in Alzheimer's Disease: from Mice to Humans.
Curr Neuropharmacol. 2024;22(14):2314-2329. PubMed.PAPER Planas-Ballvé A, Rios J, Gea M, Rabaneda-Lombarte N, Ispierto L, Grau L, Jiménez M, Cáceres C, Martínez S, Beyer K, Álvarez R, Pastor P, Vilas D
Substantia nigra hyperechogenicity and brain ventricular size as biomarkers of early dementia with Lewy bodies.
Alzheimers Res Ther. 2024 Oct 15;16(1):227. PubMed.PAPER Leggins B, Hart DM, Jackson AJ, Levenson RW, Windon CC, Merrilees J, Chiong W
Perceptions about dementia clinical trials among underrepresented populations: a nationally representative survey of U.S. dementia caregivers.
Alzheimers Res Ther. 2024 Oct 15;16(1):224. PubMed.PAPER Shen H, Yu Y, Wang J, Nie Y, Tang Y, Qu M
Plasma lipidomic signatures of dementia with Lewy bodies revealed by machine learning, and compared to alzheimer's disease.
Alzheimers Res Ther. 2024 Oct 15;16(1):226. PubMed.PAPER Tuddenham JF, Taga M, Haage V, Marshe VS, Roostaei T, White C, Lee AJ, Fujita M, Khairallah A, Zhang Y, Green G, Hyman B, Frosch M, Hopp S, Beach TG, Serrano GE, Corboy J, Habib N, Klein HU, Soni RK, Teich AF, Hickman RA, Alcalay RN, Shneider N, Schneider J, Sims PA, Bennett DA, Olah M, Menon V, De Jager PL
A cross-disease resource of living human microglia identifies disease-enriched subsets and tool compounds recapitulating microglial states.
Nat Neurosci. 2024 Oct 15; PubMed.PAPER Yu X, Liu J, Lu Y, Funahashi S, Murai T, Wu J, Li Q, Zhang Z
Early diagnosis of Alzheimer's disease using a group self-calibrated coordinate attention network based on multimodal MRI.
Sci Rep. 2024 Oct 16;14(1):24210. PubMed.PAPER Palmer JE, Wilson N, Son SM, Obrocki P, Wrobel L, Rob M, Takla M, Korolchuk VI, Rubinsztein DC
Autophagy, aging, and age-related neurodegeneration.
Neuron. 2024 Oct 8; PubMed.PAPER Cheng J, Zhai Y, Guo X, Wang X, Ma M, Ren X, Wang S, Cui H, Ren Q
Generation of an induced pluripotent stem cell line (HMSCATi004-A) from an early onset Parkinson's disease patient with PRKN gene mutation.
Stem Cell Res. 2024 Oct 9;81:103578. PubMed.Current Filters
No filters selected